Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · IEX Real-Time Price · USD
70.03
-0.97 (-1.37%)
Apr 25, 2024, 10:19 AM EDT - Market open
Ligand Pharmaceuticals Market Cap
Ligand Pharmaceuticals has a market cap or net worth of $1.24 billion as of April 25, 2024. Its market cap has decreased by -4.32% in one year.
Market Cap
1.24B
Enterprise Value
1.23B
1-Year Change
-4.32%
Ranking
Category
Stock Price
$70.03
Market Cap Chart
Since December 1, 1998, Ligand Pharmaceuticals's market cap has increased from $430.80M to $1.24B, an increase of 187.17%. That is a compound annual growth rate of 4.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 1.24B | 1.99% |
Apr 22, 2024 | 1.21B | -5.44% |
Apr 19, 2024 | 1.28B | -0.07% |
Apr 18, 2024 | 1.28B | -8.05% |
Apr 17, 2024 | 1.40B | -1.31% |
Apr 16, 2024 | 1.42B | 0.18% |
Apr 15, 2024 | 1.41B | -1.95% |
Apr 12, 2024 | 1.44B | -0.08% |
Apr 11, 2024 | 1.44B | 0.80% |
Apr 10, 2024 | 1.43B | -0.89% |
Apr 9, 2024 | 1.44B | 2.39% |
Apr 8, 2024 | 1.41B | 2.10% |
Apr 5, 2024 | 1.38B | -0.03% |
Apr 4, 2024 | 1.38B | 4.35% |
Apr 3, 2024 | 1.32B | 2.08% |
Apr 2, 2024 | 1.30B | -0.53% |
Apr 1, 2024 | 1.30B | 0.68% |
Mar 28, 2024 | 1.29B | 2.57% |
Mar 27, 2024 | 1.26B | 3.83% |
Mar 26, 2024 | 1.22B | -0.88% |
Mar 25, 2024 | 1.23B | -2.47% |
Mar 22, 2024 | 1.26B | -2.69% |
Mar 21, 2024 | 1.29B | -0.20% |
Mar 20, 2024 | 1.29B | 1.24% |
Mar 19, 2024 | 1.28B | 0.09% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Brookdale Senior Living | 1.28B |
Soleno Therapeutics | 1.28B |
Ironwood Pharmaceuticals | 1.27B |
Kiniksa Pharmaceuticals | 1.26B |
Omnicell | 1.26B |
4D Molecular Therapeutics | 1.24B |
Tarsus Pharmaceuticals | 1.23B |
Verona Pharma | 1.23B |